The Harvard chip is an early-stage demonstration rather than an industrial replacement for current DNA synthesis platforms.
DNA synthesis is vital to several processes in biopharmaceutical innovation, including the development of gene therapies, CRISPR gene editing, antisense oligonucleotides and RNA therapies. The need ...